Hasil Pencarian - Hadar Goldvaser

  • Menampilkan 1 - 18 hasil dari 18
Perbaiki Hasil
  1. 1
    Response to Soran et al.

    Response to Soran et al. oleh Daniel Reinhorn, Eitan Amir, Hadar Goldvaser

    Diterbitkan 2021-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Efficacy of immune‐checkpoint inhibitors in metastatic gastric or gastroesophageal junction adenocarcinoma by patient subgroups: A systematic review and meta‐analysis

    Efficacy of immune‐checkpoint inhibitors in metastatic gastric or gastroesophageal junction adenocarcinoma by patient subgroups: A systematic review and meta‐analysis oleh Yulia Kundel, Michal Sternschuss, Assaf Moore, Gali Perl, Baruch Brenner, Hadar Goldvaser

    Diterbitkan 2020-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Locoregional therapy in de novo metastatic breast cancer: Systemic review and meta-analysis

    Locoregional therapy in de novo metastatic breast cancer: Systemic review and meta-analysis oleh Daniel Reinhorn, Raz Mutai, Rinat Yerushalmi, Assaf Moore, Eitan Amir, Hadar Goldvaser

    Diterbitkan 2021-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Efficacy and Safety of the Addition of Internal Mammary Irradiation to Standard Adjuvant Radiation in Early-Stage Breast Cancer: A Systematic Review and Meta-Analysis

    Efficacy and Safety of the Addition of Internal Mammary Irradiation to Standard Adjuvant Radiation in Early-Stage Breast Cancer: A Systematic Review and Meta-Analysis oleh Yasmin Korzets, Dina Levitas, Ahuva Grubstein, Benjamin W. Corn, Eitan Amir, Hadar Goldvaser

    Diterbitkan 2022-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    The impact of endogenous estrogen exposures on the characteristics and outcomes of estrogen receptor positive, early breast cancer

    The impact of endogenous estrogen exposures on the characteristics and outcomes of estrogen receptor positive, early breast cancer oleh Yasmin Korzets, Orly Yariv, Raz Mutai, Assaf Moore, Tzippy Shochat, Rinat Yerushalmi, Hadar Goldvaser

    Diterbitkan 2021-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Efficacy, safety and tolerability of drugs studied in phase 3 randomized controlled trials in solid tumors over the last decade

    Efficacy, safety and tolerability of drugs studied in phase 3 randomized controlled trials in solid tumors over the last decade oleh Domen Ribnikar, Hadar Goldvaser, Zachary W. Veitch, Alberto Ocana, Arnoud J. Templeton, Boštjan Šeruga, Eitan Amir

    Diterbitkan 2021-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    The concordance of treatment decision guided by OncotypeDX and the PREDICT tool in real‐world early‐stage breast cancer

    The concordance of treatment decision guided by OncotypeDX and the PREDICT tool in real‐world early‐stage breast cancer oleh Daniel A. Goldstein, Chen Mayer, Tzippy Shochat, Daniel Reinhorn, Assaf Moore, Michal Sarfaty, Rinat Yerushalmi, Hadar Goldvaser

    Diterbitkan 2020-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Potential Association between Kaposi Sarcoma and Gout: An Exploratory Observational Study

    Potential Association between Kaposi Sarcoma and Gout: An Exploratory Observational Study oleh Assaf Moore, Idit Peretz, Lilach Yosef, Daniel A. Goldstein, Hadar Goldvaser, Suzanna Horn, Yonatan Edel, Alona Zer

    Diterbitkan 2020-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Prognostic impact of HER2-low expression in hormone receptor positive early breast cancer

    Prognostic impact of HER2-low expression in hormone receptor positive early breast cancer oleh Raz Mutai, Tamar Barkan, Assaf Moore, Michal Sarfaty, Tzippy Shochat, Rinat Yerushalmi, Salomon M. Stemmer, Hadar Goldvaser

    Diterbitkan 2021-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Associations between safety, tolerability, and toxicity and the reporting of health‐related quality of life in phase III randomized trials in common solid tumors

    Associations between safety, tolerability, and toxicity and the reporting of health‐related quality of life in phase III randomized trials in common solid tumors oleh Ramy R. Saleh, Nicholas Meti, Domen Ribnikar, Hadar Goldvaser, Alberto Ocana, Arnoud J. Templeton, Bostjan Seruga, Eitan Amir

    Diterbitkan 2020-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    The Association between Treatment for Metabolic Disorders and Breast Cancer Characteristics

    The Association between Treatment for Metabolic Disorders and Breast Cancer Characteristics oleh Hadar Goldvaser, Shulamith Rizel, Daniel Hendler, Victoria Neiman, Daniel Shepshelovich, Tzippy Shochat, Aaron Sulkes, Baruch Brenner, Rinat Yerushalmi

    Diterbitkan 2016-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    The association between smoking and breast cancer characteristics and outcome

    The association between smoking and breast cancer characteristics and outcome oleh Hadar Goldvaser, Omer Gal, Shulamith Rizel, Daniel Hendler, Victoria Neiman, Tzippy Shochat, Aaron Sulkes, Baruch Brenner, Rinat Yerushalmi

    Diterbitkan 2017-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    Adjuvant Docetaxel and Cyclophosphamide (DC) with prophylactic granulocyte colony-stimulating factor (G-CSF) on days 8 &12 in breast cancer patients: a retrospective analysis.

    Adjuvant Docetaxel and Cyclophosphamide (DC) with prophylactic granulocyte colony-stimulating factor (G-CSF) on days 8 &12 in breast cancer patients: a retrospective analysis. oleh Rinat Yerushalmi, Hadar Goldvaser, Aaron Sulkes, Irit Ben-Aharon, Daniel Hendler, Victoria Neiman, Noa Beatrice Ciuraru, Luisa Bonilla, Limor Amit, Alona Zer, Tal Granot, Shulamith Rizel, Salomon M Stemmer

    Diterbitkan 2014-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    Blood-Derived Exosomal hTERT mRNA in Patients with Lung Cancer: Characterization and Correlation with Response to Therapy

    Blood-Derived Exosomal hTERT mRNA in Patients with Lung Cancer: Characterization and Correlation with Response to Therapy oleh Ofer Rotem, Alona Zer, Lilach Yosef, Einat Beery, Hadar Goldvaser, Anna Gutkin, Ron Levin, Elizabeth Dudnik, Tamar Berger, Meora Feinmesser, Adva Levy-Barda, Meir Lahav, Pia Raanani, Orit Uziel

    Diterbitkan 2023-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    Characterization of blood-derived exosomal hTERT mRNA as a biomarker for colon cancer and Lynch syndrome

    Characterization of blood-derived exosomal hTERT mRNA as a biomarker for colon cancer and Lynch syndrome oleh Ido Laish, Ido Laish, Zohar Levi, Zohar Levi, Hussein Mahajna, Hussein Mahajna, Ahmad Albshesh, Ahmad Albshesh, Nir Horesh, Nir Horesh, Efraim Katz, Efraim Katz, Dan Feldman, Dan Feldman, Nadav Shinar, Nadav Shinar, Orit Picard, Orit Picard, Miri Yavzori, Miri Yavzori, Ella Fudim, Ella Fudim, Pia Raanani, Pia Raanani, Pia Raanani, Tamar Berger, Tamar Berger, Hadar Goldvaser, Hadar Goldvaser, Einat Beery, Einat Beery, Orit Uziel, Orit Uziel

    Diterbitkan 2022-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    Immune-Checkpoint Inhibitor-Induced Fulminant Myocarditis and Cardiogenic Shock

    Immune-Checkpoint Inhibitor-Induced Fulminant Myocarditis and Cardiogenic Shock oleh Osnat Itzhaki Ben Zadok, MD, MS, Ben Ben-Avraham, MD, Anju Nohria, MD, Katia Orvin, MD, Mithal Nassar, MD, Zaza Iakobishvili, MD, PhD, Victoria Neiman, MD, Hadar Goldvaser, MD, Ran Kornowski, MD, Tuvia Ben Gal, MD

    Diterbitkan 2019-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    Second breast cancer: recurrence score results, clinicopathologic characteristics, adjuvant treatments, and outcomes—exploratory analysis of the Clalit registry

    Second breast cancer: recurrence score results, clinicopathologic characteristics, adjuvant treatments, and outcomes—exploratory analysis of the Clalit registry oleh Shlomit S. Shachar, Michelle Leviov, Rinat Yerushalmi, Karen Drumea, Margarita Tokar, Lior Soussan-Gutman, Avital Bareket-Samish, Amir Sonnenblick, Noa Ben-Baruch, Ella Evron, Einav Nili Gal-Yam, Shani Paluch-Shimon, Gil Bar-Sela, Hadar Goldvaser, Salomon M. Stemmer

    Diterbitkan 2023-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    Clinical outcomes in estrogen receptor-positive early-stage breast cancer patients with Recurrence Score 26-30: observational real-world cohort study

    Clinical outcomes in estrogen receptor-positive early-stage breast cancer patients with Recurrence Score 26-30: observational real-world cohort study oleh Ofer Rotem, Idit Peretz, Michelle Leviov, Iryna Kuchuk, Amit Itay, Margarita Tokar, Shani Paluch-Shimon, Ofra Maimon, Rinat Yerushalmi, Karen Drumea, Ella Evron, Amir Sonnenblick, Einav Gal-Yam, Hadar Goldvaser, Yosef Samih, Rotem Merose, Avital Bareket-Samish, Lior Soussan-Gutman, Salomon M. Stemmer

    Diterbitkan 2023-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: